Royalty Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	16,408	14,061	10,948	11,306	16,312	15,050
Market Cap Growth	22.33%	28.43%	-3.17%	-30.69%	8.38%	-5.23%
Enterprise Value	26,229	23,614	20,604	19,119	25,576	23,466
Last Close Price	37.12	32.65	23.64	23.54	33.11	32.38
PE Ratio	24.99	21.41	13.20	11.01	407.00	27.62
PS Ratio	8.10	6.94	5.01	5.31	7.79	7.48
PB Ratio	1.98	1.70	1.10	1.24	1.83	1.67
P/TBV Ratio	3.47	2.97	1.63	1.92	3.11	2.97
P/OCF Ratio	7.74	6.63	4.09	4.18	8.13	8.48
EV/Sales Ratio	12.99	11.66	9.42	8.98	12.22	11.66
EV/EBITDA Ratio	19.40	17.74	-	14.11	29.44	18.36
EV/EBIT Ratio	19.45	17.78	16.51	14.16	29.62	18.65
Debt / Equity Ratio	0.92	0.92	0.74	0.61	0.75	0.69
Debt / EBITDA Ratio	5.74	5.74	-	4.10	7.66	4.88
Net Debt / Equity Ratio	0.86	0.86	0.64	0.56	0.56	0.48
Net Debt / EBITDA Ratio	5.33	5.33	-	3.77	5.79	3.38
Asset Turnover	0.13	0.13	0.13	0.14	0.13	0.14
Quick Ratio	2.39	2.39	1.43	7.78	2.11	16.77
Current Ratio	2.40	2.40	1.44	7.90	2.19	16.81
Return on Equity (ROE)	13.20%	13.20%	13.03%	17.34%	2.33%	12.32%
Return on Assets (ROA)	5.15%	5.15%	4.67%	5.62%	3.36%	5.33%
Return on Capital Employed (ROCE)	8.20%	8.20%	7.60%	9.20%	5.90%	8.20%
Earnings Yield	4.00%	4.67%	7.58%	9.08%	0.25%	3.62%
Dividend Yield	2.09%	2.30%	3.43%	3.08%	2.15%	1.85%
Payout Ratio	49.06%	49.06%	43.83%	31.57%	778.21%	46.02%
Buyback Yield / Dilution	4.99%	4.99%	1.46%	-37.66%	-5.59%	-10.48%
Total Shareholder Return	7.08%	7.29%	4.89%	-34.58%	-3.44%	-8.63%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.